DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, BETA CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, Riboflavin, Pyridoxine Hydrochloride, CYANOCOBALAMIN, Iron, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, Folic Acid, and LEVOMEFOLATE CALCIUM · DOCONEXENT 200 mg/1; NIACINAMIDE 15 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1; CHOLECALCIFEROL 25 mg/1; BETA CAROTENE 330 ug/1; ASCORBIC ACID 60 mg/1; THIAMINE MONONITRATE 1.6 mg/1; RIBOFLAVIN 1.8 mg/1; PYRIDOXINE HYDROCHLORIDE 2.5 mg/1; CYANOCOBALAMIN 25 ug/1; IRON 90 mg/1; ZINC OXIDE 25 mg/1; CUPRIC OXIDE 2 mg/1; POTASSIUM IODIDE 150 ug/1; MAGNESIUM OXIDE 20 mg/1; FOLIC ACID 680 mg/1; LEVOMEFOLATE CALCIUM 1020 ug/1 · Capsule, Liquid Filled · Oral · Exeltis USA, Inc.
NDC 00642-7473-30 · 5 BLISTER PACK in 1 BOX, UNIT-DOSE / 6 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $4.55 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
price up 3% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Exeltis USA, Inc. | DOCONEXENT 200 mg/1; NIACINAMIDE 15 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1; CHOLECALCIFEROL 25 mg/1; BETA CAROTENE 330 ug/1; ASCORBIC ACID 60 mg/1; THIAMINE MONONITRATE 1.6 mg/1; RIBOFLAVIN 1.8 mg/1; PYRIDOXINE HYDROCHLORIDE 2.5 mg/1; CYANOCOBALAMIN 25 ug/1; IRON 90 mg/1; ZINC OXIDE 25 mg/1; CUPRIC OXIDE 2 mg/1; POTASSIUM IODIDE 150 ug/1; MAGNESIUM OXIDE 20 mg/1; FOLIC ACID 680 mg/1; LEVOMEFOLATE CALCIUM 1020 ug/1 | Aug 26, 2026 | Sep 2, 2026 |
| Exeltis USA, Inc. | DOCONEXENT 9 mg/1; NIACINAMIDE 60 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 330 ug/1; CHOLECALCIFEROL 25 mg/1; BETA CAROTENE 2 mg/1; ASCORBIC ACID 25 ug/1; THIAMINE MONONITRATE 200 mg/1; RIBOFLAVIN 680 mg/1; PYRIDOXINE HYDROCHLORIDE 90 mg/1; CYANOCOBALAMIN 1020 ug/1; IRON 20 mg/1; ZINC OXIDE 15 mg/1; CUPRIC OXIDE 150 ug/1; POTASSIUM IODIDE 2.5 mg/1; MAGNESIUM OXIDE 1.8 mg/1; FOLIC ACID 1.6 mg/1; LEVOMEFOLATE CALCIUM 25 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Exeltis USA, Inc. | .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1; ASCORBIC ACID 60 mg/1; BETA CAROTENE 330 ug/1; CHOLECALCIFEROL 25 mg/1; CUPRIC OXIDE 2 mg/1; CYANOCOBALAMIN 25 ug/1; DOCONEXENT 200 mg/1; FOLIC ACID 680 mg/1; IRON 90 mg/1; LEVOMEFOLATE CALCIUM 1020 ug/1; MAGNESIUM OXIDE 20 mg/1; NIACINAMIDE 15 mg/1; POTASSIUM IODIDE 150 ug/1; PYRIDOXINE HYDROCHLORIDE 2.5 mg/1; RIBOFLAVIN 1.8 mg/1; THIAMINE MONONITRATE 1.6 mg/1; ZINC OXIDE 25 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Vitafol Fe Plus — NDC 00642-7473-30," retrieved September 3, 2026, https://drugdashboards.com/drug/00642747330.
Free to cite with attribution — see how the data is put together.